Market Place
Sourcing Support
Lunai Bioworks, Geneial Partner to Build Rare Disease Cohorts
15 Apr 2026 //
PR NEWSWIRE
Lunai Bioworks Secures Defense Collaboration For Chemical Threat
07 Apr 2026 //
PR NEWSWIRE
Lunai Bioworks Executes $20M Deal At $1.50 Conversion
26 Mar 2026 //
PR NEWSWIRE
Lunai Bio Launches Chemical Defense Consortium For $400M-$1.2B
19 Mar 2026 //
PR NEWSWIRE
Lunai Bio (NASDAQ: LNAI) Secures AI Patent For Disease Subtyping
19 Feb 2026 //
PR NEWSWIRE
Lunai Bioworks Showcases Biodefense AI Platform On CNBC
13 Feb 2026 //
PR NEWSWIRE
Lunai Bio (NASDAQ: LNAI) Initiates AI Oncology Pilot
09 Feb 2026 //
PR NEWSWIRE
Lunai Bioworks, Inc. Issues Letter To Shareholders
09 Feb 2026 //
PR NEWSWIRE BIO
Lunai Bio Launches Sentinel AI To Block Chemical Weapon
27 Jan 2026 //
PR NEWSWIRE
LNAI Expands NIH-Funded AI to Commercial Drug Discovery for AUD
26 Jan 2026 //
PR NEWSWIRE
Lunai Bio Featured in talk on Advances AI Partnership
18 Dec 2025 //
PR NEWSWIRE
Lunai Bio Targets Parkinson`s Subtypes, Speeds Proof-Of-Concept
09 Dec 2025 //
PR NEWSWIRE
Lunai Bio Secures First Licensing LOI For Tumor Regression
25 Nov 2025 //
PR NEWSWIRE
Lunai Bio Uses AI & Zebrafish Data For Early Neurotoxic Detection
30 Oct 2025 //
PHARMIWEB
Lunai Bio Launches AI-Powered Alzheimer`s Program, Expands Neuro
06 Oct 2025 //
ACCESSWIRE
Lunai Bioworks Launches Platform for AI-Driven Drug Discovery
09 Sep 2025 //
PHARMAWEB
Lunai Bioworks Enhances European Strategy Via Restructuring
08 Sep 2025 //
ACCESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.